Weaponizing human EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) for 21st century cancer therapeutics
Open Access
- 23 May 2016
- journal article
- Published by Impact Journals, LLC in Oncoscience
- Vol. 3 (7-8) , 208-219
Abstract
De-regulated EFEMP1 gene expression in solid tumors has been widely reported with conflicting roles. We dissected EFEMP1 to identify domains responsible for its cell context-dependent dual functions, with the goal being to construct an EFEMP1-derived tumor-suppressor protein (ETSP) that lacked tumor-promoting function. Exon/intron boundaries of EFEMP1 were used as boundaries of functional modules in constructing EFEMP1 variants, with removal of various module(s), and/or mutating an amino acid residue to convert a weak integrin binding-site into a strong one. A series of in vitro assays on cancerous features, and subcutaneous and intracranial xenograft-formation assays, were carried out for effects from overexpression of wild-type and variant forms of EFEMP1 in two glioma subpopulations characterized as tumor mass-forming cells (TMCs) or stem-like tumor initiating cells (STICs), where EFEMP1 showed cellcontext- dependent dual functions. One of the EFEMP1 variants was identified as the sought-after ETSP, which had a stronger tumor-suppression function in TMCs by targeting EGFR and angiogenesis, and a new tumor-suppression function in STICs by targeting NOTCH signaling and MMP2-mediated cell invasion. Therefore, ETSP may form the basis for further important research to develop a novel cancer therapy to treat many types of cancer by its tumor suppressor effect in the extracellular matrix compartment.Keywords
This publication has 31 references indexed in Scilit:
- Tumor-Specific Chromosome Mis-Segregation Controls Cancer Plasticity by Maintaining Tumor HeterogeneityPLOS ONE, 2013
- Overexpression of EFEMP1 Correlates with Tumor Progression and Poor Prognosis in Human Ovarian CarcinomaPLOS ONE, 2013
- Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signalingOncogene, 2013
- EFEMP1 (EGF containing fibulin-like extracellular matrix protein 1)Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2013
- EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartmentMolecular Cancer, 2011
- Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulationInternational Journal of Oncology, 2011
- EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cellsBiological Chemistry, 2009
- Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarkerInternational Journal of Cancer, 2009
- Failure of Pelvic Organ Support in Mice Deficient In Fibulin-3The American Journal of Pathology, 2009
- PAX6 Suppresses the Invasiveness of Glioblastoma Cells and the Expression of the Matrix Metalloproteinase-2 GeneCancer Research, 2006